ES2046204T3 - Un procedimiento para la preparacion de una 6-tioxantina. - Google Patents

Un procedimiento para la preparacion de una 6-tioxantina.

Info

Publication number
ES2046204T3
ES2046204T3 ES198787306557T ES87306557T ES2046204T3 ES 2046204 T3 ES2046204 T3 ES 2046204T3 ES 198787306557 T ES198787306557 T ES 198787306557T ES 87306557 T ES87306557 T ES 87306557T ES 2046204 T3 ES2046204 T3 ES 2046204T3
Authority
ES
Spain
Prior art keywords
group
thioxanthine
alkyl
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787306557T
Other languages
English (en)
Inventor
Peter Hofer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of ES2046204T3 publication Critical patent/ES2046204T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/22Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION TRATA DE UNA 6-TIOXANTINA DE FORMULA GENERAL (I) O DE UNA SAL FARMACEUTICAMENTE ACEPTABLE DE ELLA, EN LA QUE R3 ES UN GRUPO ALQUILO DE 2 A 6 C, CICLOALQUILO DE 3 A 7 C O CICLOALQUILALQUILO DE 4 A 8 C, Y R8 ES UN GRUPO ALQUILO DE 1 A 6 C, CICLOALQUILO DE 3 A 7 C O CICLOALQUILALQUILO DE 4 A 8 C, SIEMPRE QUE CUANDO R3 SEA UN GRUPO ETILO, N-PROPILO O N-BUTILO, R8 SEA UN ALQUILO DE 3 A 6 C, CICLOALQUILO DE 3 A 7 C, O CICLOALQUILALQUILO DE 4 A 8 C. ESTAS 6-TIOXANTINAS 3,8-DISUSTITUIDAS TIENEN UNA ACTIVIDAD BRONCODILATADORA MEJORADA.
ES198787306557T 1986-08-02 1987-07-24 Un procedimiento para la preparacion de una 6-tioxantina. Expired - Lifetime ES2046204T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868618931A GB8618931D0 (en) 1986-08-02 1986-08-02 6-thioxanthines

Publications (1)

Publication Number Publication Date
ES2046204T3 true ES2046204T3 (es) 1994-02-01

Family

ID=10602146

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787306557T Expired - Lifetime ES2046204T3 (es) 1986-08-02 1987-07-24 Un procedimiento para la preparacion de una 6-tioxantina.

Country Status (13)

Country Link
US (2) US4925847A (es)
EP (1) EP0256692B1 (es)
JP (1) JP2590120B2 (es)
AT (1) ATE80632T1 (es)
AU (1) AU601456B2 (es)
CA (1) CA1276147C (es)
DE (1) DE3781743T2 (es)
DK (1) DK161965C (es)
ES (1) ES2046204T3 (es)
GB (1) GB8618931D0 (es)
GR (1) GR3005997T3 (es)
IE (1) IE60510B1 (es)
ZA (1) ZA875346B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710503A (en) * 1985-02-07 1987-12-01 Euroceltique S.A. 6-thioxanthine derivatives
GB8618931D0 (en) * 1986-08-02 1986-09-10 Euro Celtique Sa 6-thioxanthines
JP2843634B2 (ja) * 1989-03-06 1999-01-06 協和醗酵工業株式会社 キサンチン誘導体
WO1990012797A1 (en) * 1989-04-19 1990-11-01 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Sulfer-containing xanthine derivatives as adenosin antagonists
US5290782A (en) * 1989-09-01 1994-03-01 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
JPH06102662B2 (ja) * 1989-09-01 1994-12-14 協和醗酵工業株式会社 キサンチン誘導体
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
EP0799040B1 (en) * 1994-12-13 2003-08-20 Euroceltique S.A. Trisubstituted thioxanthines
US6066641A (en) * 1994-12-13 2000-05-23 Euro-Celtique S.A. Aryl thioxanthines
US6268373B1 (en) 1995-06-07 2001-07-31 Euro-Celtique S.A. Trisubstituted thioxanthines
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
AU2603197A (en) 1996-04-10 1997-10-29 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Use of an a1 adenosine receptor agonist to treat cerebral ischaemia
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US6294541B1 (en) 1996-06-06 2001-09-25 Euro-Celtique S.A. Purine derivatives having phosphodiesterase IV inhibition activity
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
DE19882892T1 (de) 1997-12-12 2001-02-22 Euro Celtique Sa Herstellung von 3-substituierten Adeninen und Imidazopyridinen
US6319928B1 (en) 1998-11-30 2001-11-20 Euro-Celtique, S.A. Purine derivatives having phosphodiesterase IV inhibition activity
AR029347A1 (es) 1999-04-02 2003-06-25 Euro Celtique Sa Compuesto de adenina, compuesto de isognanina y 2,6-ditioxantina como precursor del mismo, uso de dichos compuestos para preparar una composicion farmaceutica y dicha composicion farmaceutica
AU2223501A (en) 1999-12-24 2001-07-09 Kyowa Hakko Kogyo Co. Ltd. Fused purine derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR188M (fr) * 1960-01-28 1961-02-20 May & Baker Ltd Nouveaux dérivés de la thioxanthine et les compositions pharmaceutiques qui les contiennent.
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4710503A (en) * 1985-02-07 1987-12-01 Euroceltique S.A. 6-thioxanthine derivatives
GB8618931D0 (en) * 1986-08-02 1986-09-10 Euro Celtique Sa 6-thioxanthines

Also Published As

Publication number Publication date
DK367787D0 (da) 1987-07-15
GB8618931D0 (en) 1986-09-10
DK161965B (da) 1991-09-02
DK367787A (da) 1988-02-03
JPS6341478A (ja) 1988-02-22
DE3781743D1 (en) 1992-10-22
AU7628687A (en) 1988-02-04
IE60510B1 (en) 1994-07-27
JP2590120B2 (ja) 1997-03-12
IE872074L (en) 1988-02-02
AU601456B2 (en) 1990-09-13
GR3005997T3 (es) 1993-06-07
ZA875346B (en) 1988-01-27
CA1276147C (en) 1990-11-13
US4925847A (en) 1990-05-15
EP0256692A2 (en) 1988-02-24
EP0256692B1 (en) 1992-09-16
DK161965C (da) 1992-02-10
ATE80632T1 (de) 1992-10-15
DE3781743T2 (de) 1993-03-25
EP0256692A3 (en) 1989-08-30
US5010081A (en) 1991-04-23

Similar Documents

Publication Publication Date Title
ES2046204T3 (es) Un procedimiento para la preparacion de una 6-tioxantina.
ES555147A0 (es) Un procedimiento para la produccion de un compuesto de tiazolidindiona hipoglicemico
NL950022I2 (nl) Analoga van mevalolacton en derivaten daarvan, werkwijzen voor hun bereiding, farmaceutische prepar aten die ze bevatten en hun toepassing als farmaceutica.
NO871408L (no) Forbedringer ved farmasoeytiske akseptable salter.
EP0270362A3 (en) Pyridinylpyrimidine derivatives, method for production thereof and a fungicide containing them as the active ingredient
IE860967L (en) Condensed oxazol-and thiazol-amines
PT83104B (en) Novel guanidinomethylbenzoic acid derivatives
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
HUT63615A (en) Process for producing new imidazole derivatives and pharmaceutical compositions comprising same as active ingredient
EP0138344A3 (en) Pyridazinones as beta-adrenoceptor antagonists
EP0205334A3 (en) Benzazepine derivatives
EP0331078A3 (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
EP0207497A3 (en) Quinolonecarboxylic acid derivative and process for its preparation
PT88957A (pt) Processo para a preparacao de derivados antibacterianos de 9-desoxo-9alpha-alil e propargil-9alpha-aza-9alpha-homoeritromicina a
EP0272596A3 (en) Theophyllinemethyldithiolan and theophyllinemethyldithianyl derivates, a method for their preparation and pharmaceutical compositions in which they are included
SE8601799D0 (sv) (-)-1beta-ethyl-1alfa-hydroxymethyl-1,2,3,4,6,7,12,12balfa-octahydroindolo/2,3-a/quinolizine, process for its preparation and pharmaceutical compositions containing same
EP0295783A3 (en) A derivative of codeine
EP0216323A3 (en) Quinolonecarboxylic acid derivatives and their preparation
PT84160B (pt) Processo para a preparacao de derivados de 1-acilaminometil-imidazo {1,2-a} quinolainas e de composicoes farmaceuticas que os contem
PT98186A (pt) Processo para a preparacao de purinil- e de pirimidinil-tetra-hidrofuranos e de composicoes farmaceuticas que os contem
DK644487A (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
ES551258A0 (es) Un procedimiento para preparar derivados de 1,6-naftiridin-2 (1h)-ona
FR2598914B1 (fr) Composition prophylactique et curative pour l'arteriosclerose
ES2061579T3 (es) Compuestos cefem y procedimientos para su preparacion.
ES2045335T3 (es) Un procedimiento para la preparacion de nuevas s-difluorometilhomocisteinas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 256692

Country of ref document: ES